Bisadducts of C60
FULL PAPER
141.61, 141.53, 141.52, 141.45, 141.30, 140.64, 138.37, 138.17, 137.89,
137.83, 71.57, 71.28, 71.09, 68.54, 67.67, 66.99, 63.39, 63.34, 59.37, 58.89,
53.16, 51.19, 14.33 ppm; FT-IR (neat): n˜ =2976, 2898, 1738 (C=O), 1614,
1492, 1225, 1205, 1097, 1058, 831, 731, 701 cmꢁ1; HR-MALDI-MS: m/z:
calcd for C87H26N2O8 ([M]+): 1226.1689; found 1226.1672.
2.2 Hz, 1H; Ar-H), 7.24–7.31 (m, overlap with CHCl3, 3H; Ar-H), 7.21
(d, J=1.9 Hz, 1H; Ar-H), 7.14 (d, J=8.4 Hz, 1H; Ar-H), 7.02 (d, J=
8.1 Hz, 1H; Ar-H), 6.90 (d, J=1.9 Hz, 1H; Ar-H), 6.10 (d, J=10.6 Hz,
1H; OCH2Ar), 5.90 (d, J=10.9 Hz, 1H; OCH2Ar), 5.08 (d, J=10.6 Hz,
1H; OCH2Ar), 5.02 (d, J=10.9 Hz, 1H; OCH2Ar), 4.71 (d, J=16.2 Hz,
2H; exo-NCH2), 4.41–4.58 (m, 6H; CH3CH2, NCH2N), 4.16 (d, J=
16.5 Hz, 1H; endo-NCH2), 4.07 (d, J=16.5 Hz, 1H; endo-NCH2), 1.51 (t,
J=7.0 Hz, 3H; CH3CH2), 1.42 ppm (t, J=7.2 Hz, 3H; CH3CH2);
13C NMR (125 MHz, CDCl3): d=163.79, 163.52, 163.39, 162.57, 147.45,
147.38, 147.24, 146.86, 146.81, 146.65, 146.60, 146.52, 146.48, 146.35,
146.23, 145.67, 145.37, 145.34, 145.28, 145.24, 145.07, 144.96, 144.94,
144.86, 144.69, 144.50, 144.40, 144.35, 144.28, 144.23, 144.20, 143.96,
143.77, 143.43, 143.25, 143.24, 143.20, 143.14, 143.09, 142.81, 142.60,
142.59, 142.30, 141.87, 141.85, 141.80, 141.53, 141.36, 141.32, 141.23,
140.68, 140.59, 140.52, 140.24, 140.03, 139.65, 138.94, 137.80, 136.11,
135.41, 135.35, 133.97, 133.79, 132.33, 131.30, 129.04, 129.00, 128.61,
128.51, 128.23, 128.05, 127.36, 126.82, 126.49, 126.29, 126.02, 125.31,
124.80, 124.61, 71.68, 71.56, 71.00, 70.86, 69.36, 68.45, 67.56, 63.49, 63.44,
60.64, 59.86, 51.54, 51.30, 14.29, 14.19 ppm (1 C missing due to signal
overlap); FT-IR (neat): n˜ =2961, 2848, 1742 (C=O), 1607, 1485, 1246,
1227, 1207, 962, 753 cmꢁ1; HR-MALDI-MS: m/z: calcd for C99H34N2O8
([M]+): 1378.2315; found 1378.2295.
(S,S,f,sC)-23b: Retention time (analytical HPLC): 23.6 min; Rf (AcOEt/
CH2Cl2 1:10)=0.20; UV/Vis (CHCl3): lmax(e)=413 (2400), 423 (1950),
491 (1700), 620 nm (420); 1H NMR (300 MHz, CDCl3): d=7.58 (d, J=
8.5 Hz, 2H; Ar-H), 7.02–7.47 (m, overlap with CHCl3, 11H; Ar-H), 6.87
(d, J=1.9 Hz, 1H; Ar-H), 5.80 (d, J=11.0 Hz, 1H; OCH2Ar), 5.70 (d,
J=11.0 Hz, 1H; OCH2Ar), 5.45 (d, J=10.7 Hz, 1H; OCH2Ar), 5.07 (d,
J=11.0 Hz, 1H; OCH2Ar), 4.68 (d, J=16.8 Hz, 2H; exo-NCH2), 4.43–
4.58 (m, 6H; CH3CH2, NCH2N), 4.13 (d, J=16.5 Hz, 1H; endo-NCH2),
3.94 (d, J=16.5 Hz, 1H; endo-NCH2), 1.49 (t, J=7.1 Hz, 3H; CH3CH2),
1.43 ppm (t, J=7.1 Hz, 3H; CH3CH2); FT-IR (neat): n˜ =2921, 2850, 1741
(C=O), 1610, 1485, 1226, 1207, 1174, 1103, 962, 771, 753 cmꢁ1; HR-
MALDI-MS: m/z: calcd for C99H34N2O8 ([M]+): 1378.2315; found
1378.2329.
out,out-3’,3’’-Diethyl (ꢀ)-3’,3’’-(4,10-Dimethyl-6H,12H-5,11-methanodi-
benzo[b,f][1,5]diazocine-1,7-diyldimethylene)
3’H,3’’H-Dicyclopro-
pa[1,9:32,33](C60-Ih)[5,6]fullerene-3’,3’,3’’,3’’-tetracarboxylate
((ꢀ)-14):
Prepared as described for (S,S,f,sA)-9 from (ꢀ)-13 (129 mg, 0.24 mmol).
Yield 95 mg (38%); UV/Vis (CHCl3): lmax(e)=416 (2900), 472 (2100),
628 (470), 692 nm (310); 1H NMR (300 MHz, CDCl3): d=6.96 (d, J=
7.8 Hz, 1H; Ar-H), 6.84–6.89 (m, 2H; Ar-H), 6.74 (d, J=7.6 Hz, 1H; Ar-
H), 5.70 (d, J=11.5 Hz, 1H; OCH2Ar), 5.42 (d, J=11.8 Hz, 1H;
OCH2Ar), 5.26 (d, J=11.8 Hz, 1H; OCH2Ar), 4.88–4.97 (m, 2H;
NCH2Ar, OCH2Ar), 4.51–4.70 (m, 6H; CH2CH3, NCH2Ar), 4.24 (d, J=
16.5 Hz, 1H; NCH2Ar), 4.14 (s, 2H; NCH2N), 2.48 (s, 3H; CH3-Ar), 2.26
(s, 3H; CH3-Ar), 1.51 ppm (t, J=7.1 Hz, 6H; CH2CH3); 13C NMR
(75 MHz, CDCl3): d=163.52, 163.33, 163.17, 163.00, 147.91, 146.85,
146.78, 146.06, 145.93, 145.88, 145.78, 145.64, 145.35, 145.31, 145.24,
145.09, 145.06, 144.93, 144.88, 144.82, 144.76, 144.71, 144.50, 144.32,
143.95, 143.91, 143.83, 143.78, 143.77, 143.14, 142.99, 142.91, 142.81,
142.75, 142.58, 142.56, 142.41, 141.99, 141.86, 141.85, 141.64, 141.58,
141.50, 141.18, 141.11, 141.03, 140.97, 140.73, 140.61, 140.13, 139.45,
139.19, 138.92, 138.42, 138.15, 134.32, 134.27, 133.96, 133.30, 129.04,
129.00, 128.94, 128.83, 127.46, 126.71, 125.84, 125.25, 70.94, 70.75, 70.53,
70.22, 66.41, 63.64, 63.40, 62.17, 52.68, 52.25, 50.21, 49.23, 17.60, 17.51,
14.54 ppm; FT-IR (neat): n˜ =2956, 2889, 1732 (C=O), 1442, 1365, 1223,
1093, 1060, 805 cmꢁ1; HR-MALDI-MS: m/z: calcd for C89H30N2O8 ([M]+):
1254.2002; found 1254.1986.
out,out-3’,3’’-Diethyl (ꢀ)-3’,3’’-(8H,16H-7,15-methanodinaphtho[2,1-b]
[2ꢁ,1ꢁ-f][1,5]diazocin-3,11-diyldimethylene)
3’H,3’’H-Dicyclopropa-
[1,9:52,60](C60-Ih)[5,6]fullerene-3’,3’,3’’,3’’-tetracarboxylate ((ꢀ)-19): Pre-
pared as described for (S,S,f,sA)-9 from (ꢀ)-18 (121 mg, 0.20 mmol) with
the following amendment: acylation was performed in DMF (5 mL).
Yield 128 mg (58%); UV/Vis (CHCl3): lmax(e)=405 (sh, 4950), 440
(2500), 470 (3700), 575 (sh, 500), 650 nm (sh, 200); 1H NMR (300 MHz,
CDCl3): d=7.93 (s, 2H; Ar-H), 7.56–7.62 (m, 6H, Ar-H), 7.29 (d, J=
8.7 Hz, 2H; Ar-H), 5.89 (d, J=10.9 Hz, 2H; OCH2Ar), 5.70 (d, J=
10.9 Hz, 2H; OCH2Ar), 5.00 (d, J=17.1 Hz, 2H; NCH2Ar), 4.65 (q, J=
7.2 Hz, 4H; OCH2CH3), 4.48 (d, J=17.1 Hz, 2H; NCH2Ar), 4.33 (s, 2H;
NCH2N), 1.58 ppm (t, J=7.2 Hz, 6H; CH3); 13C NMR (75 MHz, CDCl3):
d=164.27, 164.15, 147.24, 145.09, 145.02, 144.93, 144.45, 144.38, 143.88,
143.61, 143.30, 143.09, 143.01, 142.98, 142.83, 142.77, 142.73, 142.57,
142.41, 142.11, 142.09, 142.00, 141.82, 140.90, 140.73, 140.58, 140.56,
140.44, 140.13, 136.34, 135.91, 132.24, 131.91, 131.53, 131.18, 129.25,
128.48, 125.65, 121.76, 121.47, 69.73, 69.65, 69.08, 65.81, 63.65, 54.88,
44.83, 14.46 ppm; FT-IR (neat): n˜ =2920, 2850, 1727 (C=O), 1596, 1470,
X-ray crystal structure analyses: (ꢀ)-13: Crystal data at 220(2) K:
¯
C29H34N2O8, Mr =538.58, triclinic, space group P1 (no. 2), 1calcd
=
1.341 gcmꢁ3
, Z=2, a=8.3728(2), b=12.3137(2), c=13.5893(3) ꢃ, a=
106.060(1), b=97.703(1), g=98.613(1)8, V=1334.29(5) ꢃ3. Bruker-
Nonius CCD diffractometer, MoKa radiation, l=0.7107 ꢃ. A colorless
crystal was obtained by very slow evaporation of a solution of (ꢀ)-13 in
CH2Cl2. The structure was solved by direct methods (SIR97)[27] and re-
fined by full-matrix least-squares analysis (SHELXL-97),[28] using an iso-
tropic extinction correction, and w=1/[s2(Fo2) + (0.1092P)2 + 0.5140P],
where P=(F2o + 2F2c)/3. C29 is disordered over two orientations, only
one orientation is shown (see Supporting Information). All heavy atom
were refined anisotropically, hydrogen atoms isotropically, whereby hy-
drogen positions are based on stereochemical considerations. Final
R(F)=0.060, wR(F2)=0.171 for 385 parameters and 5036 reflections with
I>2s(I) and 3.14<q<27.47o (corresponding R values based on all 5897
reflections are 0.069 and 0.181 respectively).
1362, 1237, 1207, 1165, 1065, 1013, 806, 734 cmꢁ1
(DCTB): m/z: calcd for C95H30O8N2 ([M]+): 1326.2002; found: 1326.1980.
; HR-MALDI-MS
in,out-3’,3’’-Diethyl
(S,S)-3’,3’’-[6H,12H-5,11-Methanodibenzo[b,f]
[1,5]diazocine-2,8-diylbis(4,1-phenylenemethylene)] (f,sA)-3’H,3’’H-Dicy-
clopropa[1,9:34,35](C60-Ih)[5,6]fullerene-3’,3’,3’’,3’’-tetracarboxylate and
(R,R)-19: Crystal data at 238(2) K: C95H30O8N2·2CH2Cl2, orthorhombic,
space group P212121 (no.19), 1calcd =1.625 gcmꢁ3, Z=4, a=10.3913(13),
b=23.387(8), c=25.187(7) ꢃ, V=6121(3) ꢃ3. Nonius CAD4 diffractome-
ter, CuKa radiation, l=1.5418 ꢃ. A black crystal was obtained by very
slow evaporation of a solution of (ꢀ)-19 in a mixture of CH2Cl2 and
CHCl3. It was cut to linear dimensions of about 0.32ꢄ0.25ꢄ0.22 mm and
mounted at low temperature to prevent evaporation of enclosed solvents.
The structure was solved by direct methods (SIR97)[27] and refined by
full-matrix least-squares analysis (SHELXL-97),[28] using an isotropic ex-
tinction correction, and w=1/[s2(Fo2) + (0.1932P)2 + 2.4285P], where
P=(F2o + 2F2c)/3. One of the two CH2Cl2 molecules, included in the crys-
tal packing, is disordered over four orientations. All heavy atoms of
(R,R)-19 were refined anisotropically, hydrogen atoms isotropically,
whereby hydrogen positions are based on stereochemical considerations.
Final R(F)=0.078, wR(F2)=0.209 for 1050 parameters and 4485 reflec-
tions with I>2s(I) and 2.58<q<66.968 (corresponding R values based
on all 5751 reflections are 0.098 and 0.242, respectively).
in,out-3’,3’’-Diethyl
(S,S)-3’,3’’-[6H,12H-5,11-Methanodibenzo[b,f]
[1,5]diazocine-2,8-diylbis(4,1-phenylenemethylene)] (f,sC)-3’H,3’’H-Dicy-
clopropa[1,9:34,35](C60-Ih)[5,6]fullerene-3’,3’,3’’,3’’-tetracarboxylate
((S,S,f,sA)-23a and (S,S,f,sC)-23a): Prepared as described for (S,S,f,sA)-9
from (S,S)-22. Column chromatography (AcOEt/CH2Cl2 1:10) afforded a
mixture of diastereoisomers which were separated by preparative HPLC
on a Regis Bucky Clutcher column (500ꢄ21 mm, eluent toluene/AcOEt
93 : 7, flow rate 15 minꢁ1, detection at 350 nm), to give (S,S,f,sA)-23a
(16.5 mg, 27%) and (S,S,f,sC)-23a (4.5 mg, 5%). Similarly, (R,R,f,sC)-23b
and (R,R,f,sA)-23b were prepared starting from (R,R)-22.
(S,S,f,sA)-23a: Retention time (analytical HPLC: Regis Bucky Clutcher
column, 250ꢄ4.6 mm, eluent toluene/AcOEt 93 : 7, flow rate 1 mLminꢁ1
,
detection at 350 nm): 19.9 min; Rf (AcOEt/CH2Cl2 1:10)=0.20; UV/Vis
(CHCl3): lmax(e)=413 (2480), 423 (2010), 490 (1680), 618 nm (440);
1H NMR (500 MHz, CDCl3): d=7.60 (d, J=8.4 Hz, 2H), 7.53 (d, J=
8.4 Hz, 2H; Ar-H), 7.43 (d, J=8.1 Hz, 2H; Ar-H), 7.37 (dd, J=8.4,
Chem. Eur. J. 2005, 11, 2284 – 2294
ꢂ 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2293